Rx00250 - Valproic Acid


Name:
Valproic Acid
Rx ID:
Rx00250
Validation Level:
Phenomic Similarity:
0.599
Reference ID:
DB00313
Primary Indications:
Familial adenomatous polyposis; Fragile X syndrome
Orphan Indications:
No annotated orphan indications.
Rare Indications:
No annotated rare indications.
Common Indications:
Bipolar disorder; acute mania; psychosis; migraine headaches; complex partial seizures; complex absence seizures; absence seizures
Drug Interactions:
Acetylsalicylic acid; Asenapine; Carbamazepine; Clarithromycin; Eltrombopag; Erythromycin; Felbamate; Glycerol Phenylbutyrate; Lacosamide; Lamotrigine; ...
Click to show more...
Food Interactions:
Avoid alcohol. Do not take with milk. Take with food.

Interactive 3D Model

Interactive Drug Target Network

Interactive Bipartite Drug Repurposing Graph

Rx00250
Primary Indication
Secondary Indication

Visualize Chemical Properties

Select x-axis

Select y-axis

Disease prevalence from Electronic Health Records

Click row to show all

Disease A Disease B A∩B A∩¬B B∩¬A Odds-Ratio P-Value Adjusted P-Value
familial adenomatous polyposis bipolar disorder 1280 17923 34537 8.344 0 0.0

Chemical, Pharmacological and Biological Annotations


ATC Code:
N03AG01
Brands:
Convulex; Depakine; Deprakine; Encorate; Epilim; Valcote; Valparin
Categories:
Enzyme Inhibitors; Anticonvulsants; Antimanic Agents; GABA Agents
ChEBI ID:
9926
PubChem ID:
3121
KEGG Drug ID:
D00399
SMILE:
CCCC(CCC)C(O)=O
InChI:
1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
Classification:
Kingdom:
Organic Compounds
Superclass:
Organonitrogen Compounds
Class:
Amines
Subclass:
Polyamines
Indication:
For treatment and management of seizure disorders, mania, and prophylactic treatment of migraine headache. In epileptics, valproic acid is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and th...
Click to show more...
Pharmacodynamics:
The relationship between plasma concentration and clinical response is not well documented. One contributing factor is the nonlinear, concentration dependent protein binding of valproate which affects the clearance of the drug. Thus, monito...
Click to show more...
Description:
Valproic acid, supplied as the sodium salt valproate semisodium or divalproex sodium, is a fatty acid with anticonvulsant properties used in the treatment of epilepsy. The mechanisms of its therapeutic actions are not well understood. It ma...
Click to show more...
Mechanism:
Valproic Acid dissociates to the valproate ion in the gastrointestinal tract and then binds to and inhibits GABA transaminase. The drug's anticonvulsant activity may be related to increased brain concentrations of gamma-aminobutyric acid (G...
Click to show more...

Adsorption, Distribution, Metabolism, Excretion and Toxicity


Human Intestinal Absorption:
+
Blood Brain Barrier:
+
Caco-2 permeable:
+
P-glycoprotein substrate:
Non-substrate
P-glycoprotein inhibitor I:
Non-inhibitor
P-glycoprotein inhibitor II:
Non-inhibitor
Renal organic cation transporter:
Non-inhibitor
CYP450 2C9 substrate:
Non-inhibitor
CYP450 2D6 substrate:
Non-inhibitor
CYP450 2C19 substrate:
Non-inhibitor
CYP450 inhibitory promiscuity:
Low CYP Inhibitory Promiscuity
Ames test:
Non AMES toxic
Carcinogenicity:
Non-carcinogens
Biodegradation:
Ready biodegradable
Rat acute toxicity:
1.8543 LD50, mol/kg
hERG inhibition (predictor I):
Weak inhibitor
hERG inhibition (predictor II):
Non-inhibitor